Baidu
map

PNAS:揭示蛋白JAG1在癌症干细胞分化和转移中起关键作用

2019-01-15 MedSci 细胞

在一项新的研究中,来自美国莱斯大学和杜克大学的研究人员发现发现一种较小的蛋白--- JAG1---似乎在癌症干细胞如何发生分化和转移中发挥着关键性作用。至关重要的是,他们发现JAG1与在调节细胞命运中起着至关重要作用的Notch信号通路相互作用。相关研究结果发表在2019年1月2日的PNAS期刊上,论文标题为“Toward understanding cancer stem cell hetero

在一项新的研究中,来自美国莱斯大学和杜克大学的研究人员发现发现一种较小的蛋白--- JAG1---似乎在癌症干细胞如何发生分化和转移中发挥着关键性作用。至关重要的是,他们发现JAG1与在调节细胞命运中起着至关重要作用的Notch信号通路相互作用。相关研究结果发表在2019年1月2日的PNAS期刊上,论文标题为“Toward understanding cancer stem cell heterogeneity in the tumor microenvironment”。

上皮细胞形成排列在器官外表面的组织。间充质细胞是通常参与伤口修复等过程的迁移性细胞。上皮-间质转化(epithelial-mesenchymal transition, EMT)是一个将上皮细胞转化成迁移性的间充质细胞的过程。癌症劫持了这一过程,并通过让它停止在中间阶段而形成转移性的杂合细胞而变得最具侵袭性。

莱斯大学的研究人员之前已针对癌症干细胞如何通过控制参与胞外信号转导、伤口愈合和胚胎发育的Notch信号通路而在彼此之间和与外部世界之间进行通信提出了多种理论,比如EMT理论、干性理论、癌症代谢理论和Notch-Delta理论。在之前的研究中,他们已发现激活这种信号通路的配体是如何发生差错从而让迁移性的癌细胞保持在一起并帮助它们附着到身体新部位的结缔组织上。

在真实的系统中,所有这些理论都存在关联。在这项新的研究中,这些研究人员证实在遭受应激时,JAG1蛋白参与所有的这些理论。此外,他们还首次描述了炎性蛋白(包括细胞因子IL-6)如何扩大Notch和JAG1蛋白之间的信号,从而有助于促进杂合的上皮-间充质癌症干细胞的形成。

这项新的研究将所有这些来之不易的理论结合在一起,从而针对肿瘤如何进展形成了一个连贯性的全貌:JAG1是头号嫌疑犯,炎性蛋白起辅助作用。

这些研究人员使用了一种新的炎性乳腺癌细胞的肿瘤类器官模型,其中这种模型富含肿瘤干细胞,并发现减少JAG1的存在会影响它们的癌症干细胞样特性和增殖能力。这项研究可能导致人们开发出追踪和破坏这些细胞的疗法。

具有间充质细胞特征的癌症干细胞倾向于停留在肿瘤的边缘,在那里,它们接触周围环境,特别是炎性蛋白。肿瘤内部的癌症干细胞往往会向外扩散,形成药物更难摧毁的杂合干细胞。

这也突显了JAG1作为一种调节分子起着至关重要的作用,它将肿瘤进展的所有不同方面连接在一起。

最后,JAG1也可能作为开发新的诊断方法的靶标。

原始出处:

Federico Bocci,et al.Toward understanding cancer stem cell heterogeneity in the tumor microenvironment.PNAS. January 2, 2019 116 (1) 148-157

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1856264, encodeId=95d21856264b5, content=<a href='/topic/show?id=f32014428fc' target=_blank style='color:#2F92EE;'>#PNAS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14428, encryptionId=f32014428fc, topicName=PNAS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=08e964, createdName=drwjr, createdTime=Fri Nov 22 08:05:00 CST 2019, time=2019-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1333012, encodeId=38c81333012f7, content=<a href='/topic/show?id=2ab5e13481f' target=_blank style='color:#2F92EE;'>#癌症干细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71348, encryptionId=2ab5e13481f, topicName=癌症干细胞)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf1d2500084, createdName=1249884fm87暂无昵称, createdTime=Thu Jan 17 05:05:00 CST 2019, time=2019-01-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1570253, encodeId=424915e02531e, content=<a href='/topic/show?id=a66ae7809b1' target=_blank style='color:#2F92EE;'>#细胞分化#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77809, encryptionId=a66ae7809b1, topicName=细胞分化)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=653c15636865, createdName=karmond, createdTime=Thu Jan 17 05:05:00 CST 2019, time=2019-01-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=358273, encodeId=23fb3582e38f, content=学习了谢谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLbTp9nZtjwVrSZNxAXbAicnKQWnic2eBdJUQYhxO36XdkstSicr7FVF8p5ReH4omtmsbnLdvZLiaJJ1A/132, createdBy=8bff2327056, createdName=kafei, createdTime=Wed Jan 16 08:12:16 CST 2019, time=2019-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=358270, encodeId=5f4c3582e0e7, content=学习了,谢谢作者分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3xJXLtMtt5B40XXuPjn9xn1rBhrM6fHLkX1hI86ZoWoPJkgDkZuJNKkBfBHOcRd1fAdezg7JlHNOokohdAp3WkI/0, createdBy=32c81964262, createdName=1e145228m78(暂无匿称), createdTime=Wed Jan 16 08:09:26 CST 2019, time=2019-01-16, status=1, ipAttribution=)]
    2019-11-22 drwjr
  2. [GetPortalCommentsPageByObjectIdResponse(id=1856264, encodeId=95d21856264b5, content=<a href='/topic/show?id=f32014428fc' target=_blank style='color:#2F92EE;'>#PNAS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14428, encryptionId=f32014428fc, topicName=PNAS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=08e964, createdName=drwjr, createdTime=Fri Nov 22 08:05:00 CST 2019, time=2019-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1333012, encodeId=38c81333012f7, content=<a href='/topic/show?id=2ab5e13481f' target=_blank style='color:#2F92EE;'>#癌症干细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71348, encryptionId=2ab5e13481f, topicName=癌症干细胞)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf1d2500084, createdName=1249884fm87暂无昵称, createdTime=Thu Jan 17 05:05:00 CST 2019, time=2019-01-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1570253, encodeId=424915e02531e, content=<a href='/topic/show?id=a66ae7809b1' target=_blank style='color:#2F92EE;'>#细胞分化#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77809, encryptionId=a66ae7809b1, topicName=细胞分化)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=653c15636865, createdName=karmond, createdTime=Thu Jan 17 05:05:00 CST 2019, time=2019-01-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=358273, encodeId=23fb3582e38f, content=学习了谢谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLbTp9nZtjwVrSZNxAXbAicnKQWnic2eBdJUQYhxO36XdkstSicr7FVF8p5ReH4omtmsbnLdvZLiaJJ1A/132, createdBy=8bff2327056, createdName=kafei, createdTime=Wed Jan 16 08:12:16 CST 2019, time=2019-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=358270, encodeId=5f4c3582e0e7, content=学习了,谢谢作者分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3xJXLtMtt5B40XXuPjn9xn1rBhrM6fHLkX1hI86ZoWoPJkgDkZuJNKkBfBHOcRd1fAdezg7JlHNOokohdAp3WkI/0, createdBy=32c81964262, createdName=1e145228m78(暂无匿称), createdTime=Wed Jan 16 08:09:26 CST 2019, time=2019-01-16, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1856264, encodeId=95d21856264b5, content=<a href='/topic/show?id=f32014428fc' target=_blank style='color:#2F92EE;'>#PNAS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14428, encryptionId=f32014428fc, topicName=PNAS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=08e964, createdName=drwjr, createdTime=Fri Nov 22 08:05:00 CST 2019, time=2019-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1333012, encodeId=38c81333012f7, content=<a href='/topic/show?id=2ab5e13481f' target=_blank style='color:#2F92EE;'>#癌症干细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71348, encryptionId=2ab5e13481f, topicName=癌症干细胞)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf1d2500084, createdName=1249884fm87暂无昵称, createdTime=Thu Jan 17 05:05:00 CST 2019, time=2019-01-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1570253, encodeId=424915e02531e, content=<a href='/topic/show?id=a66ae7809b1' target=_blank style='color:#2F92EE;'>#细胞分化#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77809, encryptionId=a66ae7809b1, topicName=细胞分化)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=653c15636865, createdName=karmond, createdTime=Thu Jan 17 05:05:00 CST 2019, time=2019-01-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=358273, encodeId=23fb3582e38f, content=学习了谢谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLbTp9nZtjwVrSZNxAXbAicnKQWnic2eBdJUQYhxO36XdkstSicr7FVF8p5ReH4omtmsbnLdvZLiaJJ1A/132, createdBy=8bff2327056, createdName=kafei, createdTime=Wed Jan 16 08:12:16 CST 2019, time=2019-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=358270, encodeId=5f4c3582e0e7, content=学习了,谢谢作者分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3xJXLtMtt5B40XXuPjn9xn1rBhrM6fHLkX1hI86ZoWoPJkgDkZuJNKkBfBHOcRd1fAdezg7JlHNOokohdAp3WkI/0, createdBy=32c81964262, createdName=1e145228m78(暂无匿称), createdTime=Wed Jan 16 08:09:26 CST 2019, time=2019-01-16, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1856264, encodeId=95d21856264b5, content=<a href='/topic/show?id=f32014428fc' target=_blank style='color:#2F92EE;'>#PNAS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14428, encryptionId=f32014428fc, topicName=PNAS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=08e964, createdName=drwjr, createdTime=Fri Nov 22 08:05:00 CST 2019, time=2019-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1333012, encodeId=38c81333012f7, content=<a href='/topic/show?id=2ab5e13481f' target=_blank style='color:#2F92EE;'>#癌症干细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71348, encryptionId=2ab5e13481f, topicName=癌症干细胞)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf1d2500084, createdName=1249884fm87暂无昵称, createdTime=Thu Jan 17 05:05:00 CST 2019, time=2019-01-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1570253, encodeId=424915e02531e, content=<a href='/topic/show?id=a66ae7809b1' target=_blank style='color:#2F92EE;'>#细胞分化#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77809, encryptionId=a66ae7809b1, topicName=细胞分化)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=653c15636865, createdName=karmond, createdTime=Thu Jan 17 05:05:00 CST 2019, time=2019-01-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=358273, encodeId=23fb3582e38f, content=学习了谢谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLbTp9nZtjwVrSZNxAXbAicnKQWnic2eBdJUQYhxO36XdkstSicr7FVF8p5ReH4omtmsbnLdvZLiaJJ1A/132, createdBy=8bff2327056, createdName=kafei, createdTime=Wed Jan 16 08:12:16 CST 2019, time=2019-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=358270, encodeId=5f4c3582e0e7, content=学习了,谢谢作者分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3xJXLtMtt5B40XXuPjn9xn1rBhrM6fHLkX1hI86ZoWoPJkgDkZuJNKkBfBHOcRd1fAdezg7JlHNOokohdAp3WkI/0, createdBy=32c81964262, createdName=1e145228m78(暂无匿称), createdTime=Wed Jan 16 08:09:26 CST 2019, time=2019-01-16, status=1, ipAttribution=)]
    2019-01-16 kafei

    学习了谢谢

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1856264, encodeId=95d21856264b5, content=<a href='/topic/show?id=f32014428fc' target=_blank style='color:#2F92EE;'>#PNAS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14428, encryptionId=f32014428fc, topicName=PNAS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=08e964, createdName=drwjr, createdTime=Fri Nov 22 08:05:00 CST 2019, time=2019-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1333012, encodeId=38c81333012f7, content=<a href='/topic/show?id=2ab5e13481f' target=_blank style='color:#2F92EE;'>#癌症干细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71348, encryptionId=2ab5e13481f, topicName=癌症干细胞)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf1d2500084, createdName=1249884fm87暂无昵称, createdTime=Thu Jan 17 05:05:00 CST 2019, time=2019-01-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1570253, encodeId=424915e02531e, content=<a href='/topic/show?id=a66ae7809b1' target=_blank style='color:#2F92EE;'>#细胞分化#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77809, encryptionId=a66ae7809b1, topicName=细胞分化)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=653c15636865, createdName=karmond, createdTime=Thu Jan 17 05:05:00 CST 2019, time=2019-01-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=358273, encodeId=23fb3582e38f, content=学习了谢谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLbTp9nZtjwVrSZNxAXbAicnKQWnic2eBdJUQYhxO36XdkstSicr7FVF8p5ReH4omtmsbnLdvZLiaJJ1A/132, createdBy=8bff2327056, createdName=kafei, createdTime=Wed Jan 16 08:12:16 CST 2019, time=2019-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=358270, encodeId=5f4c3582e0e7, content=学习了,谢谢作者分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3xJXLtMtt5B40XXuPjn9xn1rBhrM6fHLkX1hI86ZoWoPJkgDkZuJNKkBfBHOcRd1fAdezg7JlHNOokohdAp3WkI/0, createdBy=32c81964262, createdName=1e145228m78(暂无匿称), createdTime=Wed Jan 16 08:09:26 CST 2019, time=2019-01-16, status=1, ipAttribution=)]
    2019-01-16 1e145228m78(暂无匿称)

    学习了,谢谢作者分享!

    0

相关资讯

Cancer Cell:把癌细胞变成脂肪细胞!脑洞打开

今天,《细胞》出版社旗下的《Cancer Cell》杂志发表了一篇极为吸引眼球的论文。来自瑞士的一支科研团队发现,一种抗癌药和一种糖尿病药物的组合,竟然能把乳腺癌细胞变成脂肪细胞,有效抑制癌症转移。这项研究的关键,在于抓住了癌细胞“变身”的时间点。原来在癌症病情发展的过程中,存在一个叫做“上皮-间充质转化”(EMT)的阶段。这一阶段内,癌细胞具有类似于“干细胞”的特质,有潜力转化成多种细胞类型。利

Nature:创新IL-2模拟蛋白,有望成为癌症免疫疗法新武器

日前,美国华盛顿大学的研究人员在《自然》杂志上发表的科学论文表示,该团队构建了一款合成蛋白,它能够模拟IL-2的作用,而且可以避免与IL-2相关的毒副作用,这一合成蛋白有望成为有力的癌症免疫疗法。

百例挑一:20cm巨大乳腺肿瘤新辅助化疗联合手术治疗1例

48岁,已婚。主诉:因“发现左乳肿物1年余,局部皮肤破溃4个月”于2018年1月21日于我科住院治疗。

Cell:癌症诊断新生物标志物

特拉维夫大学的一项新研究发现,一种名为泛素4(ubiquilin-4)的蛋白质水平升高是基因组不稳定的新生物标志物。

AGING CELL:肿瘤细胞规避衰老与干细胞特性和二甲双胍敏感性有关

大多数癌症出现在老年人身上,这些人也会积累衰老细胞。细胞衰老可以通过在培养中连续传代期间癌基因的表达或端粒缩短来诱导。

医科达成立放疗学院 助力中国放疗事业全面发展

2019年1月12日,为全方位支持中国放疗行业发展,助力中国放疗人才培养,全球精准放疗先驱医科达今日在其用户大会上,面向近千名用户及医院代表宣布成立“医科达放疗学院”。作为国内首个面向放疗行业的医教研协同发展平台,“医科达放疗学院”将从创新发展平台、临床科研合作、人才培养计划三方面来推进中国与国际放疗前沿科技接轨、壮大人才队伍、切实提升中国放疗临床应用水平。 医科达放疗学院成立 2019年1月1

Baidu
map
Baidu
map
Baidu
map